Harmony Biosciences Holdings Inc (NASDAQ: HRMY) open the trading on Wednesday, with a bit cautious approach as it glided -3.53% to $33.84, before settling in for the price of $35.08 at the close. Taking a more long-term approach, HRMY posted a 52-week range of $23.42-$41.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 546.41% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.85%. This publicly-traded company’s shares outstanding now amounts to $56.77 million, simultaneously with a float of $40.07 million. The organization now has a market capitalization sitting at $1.93 billion. At the time of writing, stock’s 50-day Moving Average stood at $36.08, while the 200-day Moving Average is $32.92.
Harmony Biosciences Holdings Inc (HRMY) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Harmony Biosciences Holdings Inc’s current insider ownership accounts for 29.74%, in contrast to 65.65% institutional ownership. According to the most recent insider trade that took place on Nov 01 ’24, this organization’s 10% Owner sold 4,000,000 shares at the rate of 30.30, making the entire transaction reach 121,210,000 in total value, affecting insider ownership by 7,218,033. Preceding that transaction, on Nov 05 ’24, Company’s 10% Owner sold 600,000 for 30.30, making the whole transaction’s value amount to 18,181,500. This particular insider is now the holder of 6,618,033 in total.
Harmony Biosciences Holdings Inc (HRMY) Earnings and Revenue Records
Harmony Biosciences Holdings Inc’s EPS increase for this current 12-month fiscal period is 8.85% and is forecasted to reach 3.18 in the upcoming year.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Trading Performance Indicators
Let’s observe the current performance indicators for Harmony Biosciences Holdings Inc (HRMY). It’s Quick Ratio in the last reported quarter now stands at 3.20. The Stock has managed to achieve an average true range (ATR) of 1.77. Alongside those numbers, its PE Ratio stands at $16.02, and its Beta score is 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.83. Similarly, its price to free cash flow for trailing twelve months is now 8.77.
In the same vein, HRMY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.11, a figure that is expected to reach 0.68 in the next quarter, and analysts are predicting that it will be 3.18 at the market close of one year from today.
Technical Analysis of Harmony Biosciences Holdings Inc (HRMY)
[Harmony Biosciences Holdings Inc, HRMY] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 62.39% While, its Average True Range was 1.80.
Raw Stochastic average of Harmony Biosciences Holdings Inc (HRMY) in the period of the previous 100 days is set at 37.79%, which indicates a major rise in contrast to 26.63% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 114.72% that was higher than 56.96% volatility it exhibited in the past 100-days period.
